WikiPsiquiatria - Posts previos
Mostrando entradas con la etiqueta light. Mostrar todas las entradas
Mostrando entradas con la etiqueta light. Mostrar todas las entradas

Gene discovery in truffle dogs sheds new light on mechanisms of childhood epilepsy

ScienceDaily (July 29, 2011) — A new epilepsy gene, LGI2, has been found in the Lagotto Romagnolo dogs, known from their gift for truffle hunting. The gene discovery made by Professor Hannes Lohi and his research group at the University of Helsinki and the Folkhälsan Rsearch Center offers a new candidate gene for human benign childhood epilepsies characterized by seizure remission.

The research is published in the online journal PLoS Genetics.

Epilepsy is the most common neurological disease in children. It occurs in 0.5 percent of all 2-10 year-old children -- during the ages when the development of the nerves in the brain is at its strongest. Childhood epilepsies are characterized by remission: the seizures set in and last for a while before they disappear completely. The mechanisms related to the remission have remained unknown. The new gene discovery made by the research group of Professor Lohi and colleagues in the Lagotto Romagnolo breed gives us new perspectives into the development of a child's brain and the remission mechanisms in childhood epilepsies. In addition, the identified gene has enabled the development of a DNA test for the Lagotto Romagnolo breed.

"This gene discovery is significant for both dogs and humans. Every third Lagotto Romagnolo carries the gene mutation in its genome and we have now developed a gene test to be used by breeders to eliminate the disease from the breed. Furthermore, the gene has not previously been linked to human epilepsies, which makes it a new candidate gene for especially childhood epilepsies," explains Hannes Lohi.

An epileptic seizure is caused by an electronic disturbance in brain function. Epilepsies form a heterogeneous group of syndromes of the nervous system in which the causes, the age of onset and the treatment vary significantly. Epilepsy is most common in the ends of the age spectrum -- childhood and old age.

"With this study we gain crucial insight into the pathways and mechanisms that control the development of a child's brain, optimizing its structure for electrical stability and seizure-freedom in the rest of adult life. This study will open vast avenues of research in uncovering the molecular bases of the transformation of the brain from its immature state in infancy to its maximal abilities in adolescence and early adulthood," says Dr. Berge Minassian, senior co-author of the study and a senior scientist and pediatric epileptologist at The Hospital for Sick Children in Toronto, Canada.

Epilepsy is the most common disease of the nervous system in dogs, and different types of hereditary epilepsy exist in many breeds. Lohi has previously identified the first canine epilepsy gene, EPM2B, in the Miniature Dachshund. The newly identified mutation in the LGI2 gene is the first idiopathic epilepsy gene in dogs.

Previous clinical studies have demonstrated the focal remitting epilepsy in Lagotto Romagnolo puppies. Seizures causing tremor, trembling, shaking and wheezing set in at around four weeks of age and last for one to two months before a complete cease. The seizure frequency varies significantly even within the same litter and severity can vary from very mild to attacks of unconsciousness. The mildest seizures may even go unnoticed. Between seizures some dogs may experience ataxic episodes with difficulties in movement coordination and motor function. Lagotto's epilepsy resembles human benign childhood epilepsies with remission.

"We tested the mutation in about 40 different breeds and in dogs with a very early age of onset of epilepsy, but it was present only in Lagottos. On the other hand, the study revealed another form of epilepsy in the breed, unconnected with this mutation and with an age of onset in adulthood. In addition, the breed has a progressive juvenile ataxia (lack of motor coordination) with similar onset and symptoms to juvenile epilepsy except that it does not remit -- ataxic puppies have to be euthanized usually by the first year of life. More samples are needed for both adult-onset epilepsy and ataxia to enable us to investigate their genetics further," says a primary author of the study, Eija Seppälä, PhD.

Together with his research group Lohi has built a large canine DNA bank in Finland with over 35 000 samples from 250 breeds. The DNA bank has played an important role in the present and ongoing studies.

"We also study the epilepsies in other breeds, and several new epilepsy loci have been discovered recently. I believe that there will be more similar success stories such as the case of the truffle dogs in future. Canine epilepsies are natural, spontaneous and resemble human epilepsies, offering us a great opportunity to advance the epilepsy research for the benefit of both humans and dogs," Lohi asserts.

Lohi's research group operates in two campuses at the Faculties of Veterinary Medicine and Medicine at the University of Helsinki and also at the Folkhälsan Research Center. His research is funded by several sources including the Academy of Finland, the European Union, the Sigfrid Jusélius Foundation, the Finnish Cultural Foundation, the Jane and Aatos Erkko Foundation, Biocentrum Helsinki, University of Helsinki Research Funds and Folkhälsan.

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by Helsingin yliopisto (University of Helsinki), via AlphaGalileo.

Journal Reference:

Eija H. Seppälä, Tarja S. Jokinen, Masaki Fukata, Yuko Fukata, Matthew T. Webster, Elinor K. Karlsson, Sami K. Kilpinen, Frank Steffen, Elisabeth Dietschi, Tosso Leeb, Ranja Eklund, Xiaochu Zhao, Jennifer J. Rilstone, Kerstin Lindblad-Toh, Berge A. Minassian, Hannes Lohi. LGI2 Truncation Causes a Remitting Focal Epilepsy in Dogs. PLoS Genetics, 2011; 7 (7): e1002194 DOI: 10.1371/journal.pgen.1002194

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.



View the original article here

Controlling movements with light

ScienceDaily (July 21, 2011) — Researchers have succeeded in controlling the activity of certain nerve cells using light, thus influencing the movements of mice. By changing special receptors in nerve cells of the cerebellum such that they can be activated and deactivated by light, the researchers have shown that the signaling pathways, which are activated by the receptors play a crucial role in controlling movement.

Unlike conventional methods, with the so-called optogenetics, the researchers were able to target one cell type. "We are now going to use this method to find out exactly what goes wrong in the nerve cells in movement disorders such as ataxias," said Prof. Dr. Stefan Herlitze (RUB Department for Biology and Biotechnology).

The researchers report is in the Journal of Biological Chemistry.

The Bochum team examined a specific signalling pathway that is controlled by a so-called G-protein-coupled receptor. This pathway is important for the modulation of activity in complex neuronal networks. Disturbances of the function can, for example, have an effect on emotional and motor behaviours. "We know that the activity pattern of the Purkinje cells in the cerebellum is crucial for the coordination of movements," Herlitze explained. "It is unclear, however, what contribution is made by the individual receptors." In conventional studies, researchers use drugs that inhibit or stimulate specific proteins in nerve cells to investigate the contribution of these proteins to the activity of the cells. However, Herlitze's team was interested in a protein (G-protein-coupled receptor) which occurs in various cell types. Had the researchers administered a drug, they would not only have deactivated the receptor in the Purkinje cells, but in all cell types in which it occurs. The drug method therefore makes it impossible to observe the contribution of the receptor in the Purkinje cells in isolation.

Optogenetics: replacing drugs with light

To avoid this problem, Herlitze's team replaced the drugs with proteins that are activated by light. Using genetic methods, the researchers integrated rhodopsin, the light-sensitive protein of the eye, into the Purkinje cells of mice. They also implanted a laser probe in the cerebellum, with which they illuminated the rhodopsin. The light-activated rhodopsin then activated the G-protein-coupled receptor in the Purkinje cells, while the same receptors in other cell types remained inactive. The RUB Department of General Zoology and Neurobiology has been instrumental in establishing this method worldwide.

Investigated receptor is crucial for movement control

The researchers found that activation of the G-protein-coupled receptor changed the activity pattern of the Purkinje cells. Herlitze's team had to expose the rhodopsin to light for several seconds to achieve these effects. A twenty to thirty percent reduction in cell activity was sufficient to induce visible motor deficits in the behaviour of the mice, such as impaired balance or coordination problems. "We were able to demonstrate for the first time that the modulation of a specific G-protein-coupled receptor in the Purkinje cells is of crucial importance for the control and coordination of movement," summed up Herlitze.

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by Ruhr-University Bochum, via EurekAlert!, a service of AAAS.

Journal Reference:

Gutierrez, D.V., Mark, M.D., Masseck, O., Maejima, T., Kuckelsberg, D., Hyde, R.A., Krause, M., Kruse, W., Herlitze, S. Optogenetic control of motor coordination by Gi/o protein-coupled vertebrate rhodopsin in cerebellar Purkinje cells. J. Biol. Chem., 2011 DOI: 10.1074/jbc.M111.25367

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.



View the original article here

Medscape Psychiatry

Scientific American - Mind & Brain

Nature Reviews Neuroscience - Issue - nature.com science feeds

Nature Reviews Neuroscience - AOP - nature.com science feeds

Nature Neuroscience - Issue - nature.com science feeds

Nature Neuroscience - AOP - nature.com science feeds

Translational Psychiatry

Neuropsychopharmacology - AOP - nature.com science feeds

Neuropsychopharmacology - Issue - nature.com science feeds